Comparison of anti-angiogenesis drugs targeting VEGF receptors and the VEGF co-mceptor Neuropilin.

被引：0
|
作者：
Mac Gabhann, Feilim [1 ]
Popel, Aleksander S. [1 ]
机构：
[1] Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA
来源：
FASEB JOURNAL | 2007年 / 21卷 / 06期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：A747 / A747
页数：1
相关论文
共 50 条
  • [41] Recent advances in ocular drug delivery systems and targeting VEGF receptors for management of ocular angiogenesis: A comprehensive review
    Narayana, Soumya
    Ahmed, Mohammed Gulzar
    Gowda, B. H. Jaswanth
    Shetty, Pallavi K.
    Nasrine, Arfa
    Thriveni, M.
    Noushida, Nadira
    Sanjana, A.
    FUTURE JOURNAL OF PHARMACEUTICAL SCIENCES, 2021, 7 (01)
  • [42] Sulforaphane exerts anti-angiogenesis effects against hepatocellular carcinoma through inhibition of STAT3/HIF-1α/VEGF signalling
    Liu, Peng
    Atkinson, Samuel J.
    Akbareian, Sophia E.
    Zhou, Zhigang
    Munsterberg, Andrea
    Robinson, Stephen D.
    Bao, Yongping
    SCIENTIFIC REPORTS, 2017, 7
  • [43] Vector-based RNAi, a novel tool for isoform-specific knock-down of VEGF and anti-angiogenesis gene therapy of cancer
    Zhang, L
    Yang, N
    Mohamed-Hadley, A
    Rubin, SC
    Coukos, G
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2003, 303 (04) : 1169 - 1178
  • [44] Sulforaphane exerts anti-angiogenesis effects against hepatocellular carcinoma through inhibition of STAT3/HIF-1α/VEGF signalling
    Peng Liu
    Samuel J. Atkinson
    Sophia E. Akbareian
    Zhigang Zhou
    Andrea Munsterberg
    Stephen D. Robinson
    Yongping Bao
    Scientific Reports, 7
  • [45] Treatment outcome of anti-angiogenesis through VEGF-pathway in the management of gastric cancer: A systematic review of phase II and III clinical trials
    Mawalla B.
    Yuan X.
    Luo X.
    Chalya P.L.
    BMC Research Notes, 11 (1)
  • [46] Development and evaluation of 99mTc-labeled anti-VEGF peptide targeting neuropilin-1 as potential tumor imaging agent
    Camacho, Ximena
    Gambini, Juan
    Fernanda Garcia, Maria
    Oddone, Natalia
    Fernandez, Marcelo
    Maria Zamora, Ana
    Cabral, Pablo
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57
  • [47] Co-delivery of VEGF siRNA and Etoposide for Enhanced Anti-angiogenesis and Anti-proliferation Effect via Multi-functional Nanoparticles for Orthotopic Non-Small Cell Lung Cancer Treatment
    Li, Fang
    Wang, Yu
    Chen, Wei-liang
    Wang, Dan-dan
    Zhou, Ye-juan
    You, Ben-gang
    Liu, Yang
    Qu, Chen-xi
    Yang, Shu-di
    Chen, Meng-tian
    Zhang, Xue-nong
    THERANOSTICS, 2019, 9 (20): : 5886 - 5898
  • [48] Sequential delivery of VEGF siRNA and paclitaxel for PVN destruction, anti-angiogenesis, and tumor cell apoptosis procedurally via a multi-functional polymer micelle
    Yang, Yanfang
    Meng, Yingying
    Ye, Jun
    Xia, Xuejun
    Wang, Hongliang
    Li, Lin
    Dong, Wujun
    Jin, Dujia
    Liu, Yuling
    JOURNAL OF CONTROLLED RELEASE, 2018, 287 : 103 - 120
  • [49] Epigenetic modulators hydralazine and sodium valproate act synergistically in VEGI-mediated anti-angiogenesis and VEGF interference in human osteosarcoma and vascular endothelial cells
    Kumanishi, Shunsuke
    Yamanegi, Koji
    Nishiura, Hiroshi
    Fujihara, Yuki
    Kobayashi, Kenta
    Nakasho, Keiji
    Futani, Hiroyuki
    Yoshiya, Shinichi
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2019, 55 (01) : 167 - 178
  • [50] Comparison of Syringes With Intravitreal Anti-VEGF Drugs: Particle Burden and Protein Aggregates in Brolucizumab, Aflibercept and Bevacizumab
    Schargus, Marc
    Kopp, Katharina Tatjana
    Helbig, Constanze
    Frings, Andreas
    Winter, Gerhard
    TRANSLATIONAL VISION SCIENCE & TECHNOLOGY, 2021, 10 (09):
12345